Category Archives: Business and Investments

Latest From Business and Investments

Many Biotechs Still Operating at Low Cash Levels

The percentage of public biotech companies that still operate with less than a year of cash is at 38% (see chart).  Given that we already lost a number of companies in 2009 due to lack of cash to fund research, this is a high percentage for the remaining companies. This is even more interesting when you consider that 2009 was a big year for Follow-On Offerings (FOPOs) and Private Investments in Public Equity (PIPEs). The Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: ,

Fewer Public Biotechs in 2010 vs 2008

Back in January 2008, we were tracking 394 “active” public biotech companies. (By “active”, we mean companies that are filing with the SEC and not in bankruptcy or in a major restructuring due financial distress.) As of January 2010, we have 295 – a loss of ~25%. About 48% of the companies that are no longer “active” have been acquired and 52% have gone out of business, filed bankruptcy, or are no longer filing with Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: ,

BIO Asia partnering is heating up!

Less than a week to go until the 7th Annual BIO Asia International Partnering Conference and it is clear that we are on pace to beat the number of total partnering meetings done from last year. Check out the little snippet from Google analytics to the right.  This past Monday represented the highest day of activity within the system to date! In 2008, we had a total of 693 partnering meetings scheduled at the conference Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Evolution of BIO Partnering

I joined BIO in the summer of 2008, just as the global biotechnology community headed towards sunny San Diego.  This was my first experience with the scale of partnering that occurs at that meeting.  Constantly trying to be on the forefront of innovation, the BIO BD team has put forth an increased effort into converting their partnering software form a utilitarian piece of software into something that is much more. The last 18 months have Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , ,

Sector Performance Since the 2007 Market Peak

How does the biotech sector performance rank against the 10 S&P sectors since the S&P500 peak back on October 9th, 2007? As of January 6th, 2010, the Nasdaq Biotech Index (NBI) outperformed all 10 sectors, including the overall healthcare sector and the other traditionally defensive sectors: utilities and consumer staples. The AMEX Biotech Index (BTK) had some unique events in 2009 that helped it not only outperform every sector, but remain in double digit positive Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: ,